Patents by Inventor Jingdong Su

Jingdong Su has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Thienopyranones as kinase inhibitors
    Patent number: 8557807
    Abstract: The invention, relates to compounds of formula I (or pharmaceutically acceptable salts thereof) as defined herein, pharmaceutical compositions thereof, and their use in manufactures and methods for modulating biological processes including inhibition of kinase activity such as P1-3 kinase.
    Type: Grant
    Filed: January 23, 2009
    Date of Patent: October 15, 2013
    Assignee: Signal Rx Pharmaceuticals, Inc.
    Inventors: Guillermo A. Morales, Kevin T. Weber, Jessica M. Newblom, Xiaodong Peng, Jingdong Su, Joseph R. Garlich
  • THIENOPYRANONES AS KINASE INHIBITORS
    Publication number: 20100310466
    Abstract: The invention, relates to compounds of formula I (or pharmaceutically acceptable salts thereof) as defined herein, pharmaceutical compositions thereof, and their use in manufactures and methods for modulating biological processes including inhibition of kinase activity such as PI-3 kinase.
    Type: Application
    Filed: January 23, 2009
    Publication date: December 9, 2010
    Inventors: Guillermo A. Morales, Kevin T. Weber, Jessica M. Newblom, Xiaodong Peng, Jingdong Su, Joseph R. Garlich
  • PI-3 kinase inhibitor prodrugs
    Patent number: 7662977
    Abstract: The invention provides novel prodrugs of inhibitors of PI-3 kinase. The novel compounds are LY294002 and analogs thereof comprising a reversibly quaternized amine.
    Type: Grant
    Filed: December 21, 2007
    Date of Patent: February 16, 2010
    Assignee: Semafore Pharmaceuticals, Inc.
    Inventors: Joseph R. Garlich, Donald L. Durden, Mary Patterson, Jingdong Su, Robert G. Suhr
  • PI-3 KINASE INHIBITOR PRODRUGS
    Publication number: 20080188423
    Abstract: The invention provides novel prodrugs of inhibitors of PI-3 kinase. The novel compounds are LY294002 and analogs thereof comprising a reversibly quaternized amine.
    Type: Application
    Filed: December 21, 2007
    Publication date: August 7, 2008
    Inventors: Joseph R. Garlich, Donald L. Durden, Mary Patterson, Jingdong Su, Robert G. Suhr
  • PI-3 kinase inhibitor prodrugs
    Patent number: 7396828
    Abstract: The invention provides prodrugs of inhibitors of PI-3 kinase. The compounds are LY294002 and analogs thereof comprising a reversibly quaternized amine.
    Type: Grant
    Filed: April 20, 2005
    Date of Patent: July 8, 2008
    Assignee: Semafore Pharmaceuticals, Inc.
    Inventors: Joseph R. Garlich, Donald L. Durden, Mary Patterson, Jingdong Su, Robert G. Suhr
  • Pten Inhibitors
    Publication number: 20070203098
    Abstract: The therapeutic use of inhibitors of PTEN activity in the treatment of PTEN-mediated diseases, conditions, and injuries is disclosed.
    Type: Application
    Filed: April 6, 2005
    Publication date: August 30, 2007
    Applicant: Semafore Pharmaceuticals, Inc.
    Inventors: Joseph Garlich, Donald Durden, Taxiarchis Georgiadis, Jingdong Su, Xiaodong Peng, Tim Smith
  • PI-3 kinase inhibitor prodrugs
    Patent number: 6949537
    Abstract: The invention provides novel prodrugs of inhibitors of PI-3 kinase. The novel compounds are LY294002 and analogs thereof comprising a reversibly quaternized amine.
    Type: Grant
    Filed: April 5, 2004
    Date of Patent: September 27, 2005
    Assignee: Semafore Pharmaceuticals, Inc.
    Inventors: Joseph R. Garlich, Donald L. Durden, Mary Patterson, Jingdong Su, Robert G. Suhr
  • PI-3 kinase inhibitor prodrugs
    Publication number: 20050203173
    Abstract: The invention provides novel prodrugs of inhibitors of PI-3 kinase. The novel compounds are LY294002 and analogs thereof comprising a reversibly quaternized amine.
    Type: Application
    Filed: April 20, 2005
    Publication date: September 15, 2005
    Inventors: Joseph Garlich, Donald Durden, Mary Patterson, Jingdong Su, Robert Suhr
  • PI-3 kinase inhibitor prodrugs
    Publication number: 20040242631
    Abstract: The invention provides novel prodrugs of inhibitors of PI-3 kinase. The novel compounds are LY294002 and analogs thereof comprising a reversibly quaternized amine.
    Type: Application
    Filed: April 5, 2004
    Publication date: December 2, 2004
    Inventors: Joseph R. Garlich, Donald L. Durden, Mary Patterson, Jingdong Su, Robert G. Suhr